Abstract

BackgroundAlthough recent molecular analyses have improved our knowledge regarding gastric cancer (GC) biology, the molecular mechanisms that confer metastatic potential to GC remain poorly understood. In this study, we intend to explore the function and characterize the underlying mechanism of long noncoding RNA RNF144A-AS1 in GC metastasis and outgrowth.MethodsThe expression of RNF144A-AS1, miR-30c-2-3p, and Lysyl oxidase (LOX) was detected by quantitative real-time PCR assay. Fluorescence in situ hybridization and subcellular fractionation assay determined the cellular localization of RNF144A-AS1. Cell counting kit 8 assay, transwell assay, and tube formation assay were performed to detect the effect on cell proliferation, migration, invasion, and angiogenesis, respectively. Animal models were also applied to verify the effect on tumor metastasis, outgrowth, and angiogenesis. Bioinformatic analysis, luciferase reporter assay, and RNA immunoprecipitation (RIP) assay explored the interactions among RNF144A-AS1, miR-30c-2-3p, and LOX. Gene regulation was further validated by knockdown of Dicer or mutating the miRNA binding sites on RNF144A-AS1 and LOX 3ʹUTR. Cells were treated with recombinant human TGF-β1 (Transforming Growth Factor β1) to explore the effect of TGF-β1 on RNF144A-AS1. Western blot and immunohistochemistry were used to detect protein expression.ResultsThe expression of RNF144A-AS1 was significantly upregulated in GC tissues and was associated with poor prognosis and later-stage diseases. Hypoxia stimulated the expression of RNF144A-AS1 in a HIF-1α-independent manner. Additionally, RNF144A-AS1 was also induced by TGF-β1. Loss and gain of function assays revealed that RNF144A-AS1 promoted tumor metastasis, angiogenesis, and proliferation. Mechanism exploration indicated RNF144A-AS1 served as a microRNA decoy of miR-30c-2-3p to release LOX. Gene Set Enrichment Analysis further suggested LOX and RNF144A-AS1 were enriched in the same gene sets, emphasizing the internal mechanism connection between these two genes.ConclusionsTGF-β1- and hypoxia-inducible RNF144A-AS1 promoted tumor metastasis, angiogenesis, and proliferation through targeting the miR-30c-2-3p/LOX axis in GC, highlighting the value of the RNF144A-AS1/miR-30c-2-3p/LOX axis in therapeutic interventions of GC.

Highlights

  • Gastric cancer (GC) is a common neoplastic disease with over 1 million new cases and an estimated 769,000 deaths worldwide in 2020, resulting in a huge socioeconomicLi et al Cell Biosci (2021) 11:177 burden to the world [1]

  • To identify critical long noncoding RNA (lncRNA) implicated in gastric carcinogenesis, integrated analysis of gene expression profiles from the the Cancer Genome Atlas (TCGA) database was conducted, and the results suggested the expression of RNF144A-AS1 was significantly upregulated in gastric cancer (GC) tissues (n = 375; Fig. 1A)

  • Enhanced expression of RNF144A-AS1 was verified in 60 paired GC tissues, in which 78% of these GC tissues presented with increased expression of RNF144A-AS1 compared with adjacent normal tissues (Fig. 1B, C)

Read more

Summary

Introduction

Gastric cancer (GC) is a common neoplastic disease with over 1 million new cases and an estimated 769,000 deaths worldwide in 2020, resulting in a huge socioeconomicLi et al Cell Biosci (2021) 11:177 burden to the world [1]. The roles of long noncoding RNA (lncRNA) in carcinogenesis and malignant processes have attracted accumulating attention [6]. Long noncoding RNAs are a class of non-coding RNAs with a length of more than 200 nucleotides [7]. It is believed the mechanisms of action of lncRNA are associated with its subcellular localization [8]. Recent molecular analyses have improved our knowledge regarding gastric cancer (GC) biology, the molecular mechanisms that confer metastatic potential to GC remain poorly understood. We intend to explore the function and characterize the underlying mechanism of long noncoding RNA RNF144A-AS1 in GC metastasis and outgrowth

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call